Fda Drug Approval Process Cases in D.C. Circuit

Browse 1 fda drug approval process cases decided by D.C. Circuit. AI-powered summaries, holdings, and legal analysis.

1
Cases
1
Mixed

Fda Drug Approval Process Opinions from D.C. Circuit (1)

Vanda Pharmaceuticals, Inc. v. FDA

D.C. Circuit Reverses FDA's Rejection of Vanda's Hetlioz sNDA for Pediatric Use

D.C. Circuit · 2025-08-15 · Mixed · Impact: 65/100

Vanda Pharmaceuticals, Inc. v. FDA, decided by D.C. Circuit on August 15, 2025, resulted in a mixed outcome. The D.C. Circuit reviewed the FDA's refusal to approve Vanda Pharmaceuticals' supplemental ...

Frequently Asked Questions

Q: How many fda drug approval process cases has D.C. Circuit decided?

CaseLawBrief currently tracks 1 fda drug approval process cases from D.C. Circuit. This number is updated as new opinions are published.

Q: What types of outcomes occur in fda drug approval process cases at D.C. Circuit?

Outcome breakdown: Mixed: 1.

Q: Where can I find plain English summaries of fda drug approval process rulings from D.C. Circuit?

Each case page on CaseLawBrief includes an AI-generated plain English summary, key holdings, and legal analysis. Click any case above to read its full analysis.

Explore More

All D.C. Circuit Cases All Fda Drug Approval Process Cases All Courts All Topics Search